Premium
EFFECT OF FUSARIC ACID (A DOPAMINE β‐HYDROXYLASE INHIBITOR) ON PHAEOCHROMOCYTOMA
Author(s) -
NAGASAKA A.,
HARA I.,
IMAI Y.,
UCHIKAWA T.,
YAMAUCHI K.,
SUZUKI S.,
TAKATSUKI K.,
TOMITA A.,
NIINOMI M.,
NAKAGAWA H.,
ITATSU T.,
HIDAKA H.
Publication year - 1985
Publication title -
clinical endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.055
H-Index - 147
eISSN - 1365-2265
pISSN - 0300-0664
DOI - 10.1111/j.1365-2265.1985.tb00142.x
Subject(s) - fusaric acid , dopamine , catecholamine , endocrinology , medicine , pheochromocytoma , dopamine beta monooxygenase , neuroblastoma , blood pressure , norepinephrine , biology , genetics , horticulture , fusarium , cell culture
SUMMARY Fusaric acid, an inhibitor of dopamine β‐hydroxylase, which converts dopamine to noradrenaline, lowered the blood pressure and induced a subjective improvement in patients with phaeochromocytoma. These effects may be due either to an impairment of catecholamine biosynthesis or to a direct action on the blood vessels. The use of this drug in the treatment of patients with inoperable malignant phaeochromocytoma or neuroblastoma may improve symptoms and prolong survival.